Additionally, IKZF1 deletion in B‐ALL shows a more stem cell‐like signature in gene expression profiling than the wild‐type IKZF1, and the expression of a stem cell program has been associated with drug resistance and poor outcomes in other types of leukemia [39, 40, 41]. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.